Belay Summit™
multi-analyte tDNA in CSF
Advanced liquid biopsy in CSF
Belay Summit detects mutations and aneuploidy from tumor-derived DNA in CSF to help inform the diagnosis and management of primary and secondary CNS malignancies.
Why choose Belay Summit?
- Sequencing of tDNA in CSF can identify genetic alterations commonly associated with CNS cancers
- Collection of CSF is well tolerated and currently included in the standard of care for patients with suspicion of CNS tumors
- Turnaround time is average 7-10 days from receipt of specimen